sb 203580 has been researched along with Blood Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, B; Meng, X; Sun, W; Xue, D; Zhang, W | 1 |
1 other study(ies) available for sb 203580 and Blood Diseases
| Article | Year |
|---|---|
Screening of differentially expressed protein kinases in bone marrow endothelial cells and the protective effects of the p38a inhibitor SB203580 on bone marrow in liver fibrosis.
Topics: Animals; Apoptosis; Blood Platelets; Bone Marrow Cells; Disease Models, Animal; Endothelial Cells; Gene Expression Regulation; Hematologic Diseases; Humans; Imidazoles; Liver Cirrhosis; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyridines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Signal Transduction | 2016 |